1 Min Read
Feb 22 (Reuters) - DIAMYD MEDICAL AB:
* THE GABA/DIAMYD® TRIAL IN THE US FULLY RECRUITED THIS SUMMER
* NO SERIOUS SIDE EFFECTS HAVE BEEN REPORTED AND TREATMENT APPEARS TO BE SAFE. Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.